Since the Food and Drug Administration issued a proposed rule that will place laboratory developed tests (LDTs) under its regulatory purview in October, the question has been how long it would take for the agency to deliver its final rule.
After the comment period on the proposed rule ended in December, skeptics argued it was unlikely the FDA would meet a deadline imposed by the White House and complete a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?